Log In
BCIQ
Print this Print this
 

GSK2586881 (formerly APN01)

  Manage Alerts
Collapse Summary General Information
Company Apeiron Biologics AG
DescriptionRecombinant human angiotensin-converting enzyme 2 (rhACE2)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$17.6M

$330.9M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/08/2010

Undisclosed

$17.6M

$330.9M

Get a free BioCentury trial today